Regulus Therapeutics expands executive team
This article was originally published in Scrip
Regulus Therapeutics has appointed Mary Glanville senior vice-president of human capital and Christopher Aker senior director of legal affairs and secretary. Ms Glanville will be responsible for recruitment and retention, and previously served for ten years as vice-president of human capital at Anadys Pharmaceuticals. Mr Aker will take responsibility for all legal, corporate and intellectual property matters, and most recently served as corporate counsel and senior director of administration at Phenomix.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.